Assignee
LINNANE PHARMA AB
SE·3 granted patents·7 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
10 records- 0175US2026009034A1Novel therapyLINNANE PHARMA AB·Filed 2025·Application pending·0 cites
- 0274US2025388889A1Lon protease, alpha-hemolysin, ck1-alpha-1; c-myb inhibitor or a cebp-delta inhibitor as therapeuticsLINNANE PHARMA AB·Filed 2025·Application pending·0 cites
- 0358US2023055209A1Lon protease, alpha-hemolysin, ck1-alpha-1; c-myb inhibitor or a cebp-delta inhibitor as therapeuticsLINNANE PHARMA AB·Filed 2020·Application pending·0 cites
- 0454US2023372450A1Method for preparing a composition comprising an unfolded proteinLINNANE PHARMA AB·Filed 2021·Application pending·0 cites
- 0545US2020155534A1Novel therapyLINNANE PHARMA AB·Filed 2017·Application pending·0 cites
- 0644US10287585B2TherapyLINNANE PHARMA AB·Filed 2016·Granted May 14, 2019·0 cites·7 claims
- 0744US2019316135A1Novel therapyLINNANE PHARMA AB·Filed 2017·Application pending·0 cites
- 0841US12533393B2Vibrio cholerae protein for use against cancerLINNANE PHARMA AB·Filed 2020·Granted Jan 27, 2026·0 cites·13 claims
- 0934US2019240287A1Inhibitor of rna polymerase iiLINNANE PHARMA AB·Filed 2017·Application pending·0 cites
- 1032US11034742B2Peptides with antibiotic potential against Mycobacterium tuberculosisLINNANE PHARMA AB·Filed 2018·Granted Jun 15, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when LINNANE PHARMA AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →